Soligenix Stock: 2.86% Gain Masks Thin Liquidity, Low Cap, & Volatile RiskSoligenix’s recent 2.86% rise masks a fragile market cap, thin liquidity and extreme volatility—an investor warning to seek steadier biotech options.SOLIGENIX INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Vanessa Liu 23/10/2026, 06:53 3 minutes to read
Soligenix (SNGX) Stock Drops 2.86% – Current Price $0.35 and Market Cap $7.7 MSoligenix (SNGX) stock dips 2.9% to $0.35 amid a weak 24‑hour market; compare its performance to peers and learn why investors watch its biotech focus.SOLIGENIX INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Elliot Mercer 21/10/2026, 11:07 One minute to read